Skip to main content
Clinical Trials/EUCTR2016-003339-39-ES
EUCTR2016-003339-39-ES
Active, not recruiting
Phase 1

A randomized, controlled and double-blind trial of intravenous azithromycin versus intravenous erythromycin as a single dose prior to endoscopy in upper gastrointestinal bleeding

JOSÉ MARÍA PALAZÓN AZORÍ0 sitesApril 7, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
pper gastrointestinal haemorrhage
Sponsor
JOSÉ MARÍA PALAZÓN AZORÍ
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
JOSÉ MARÍA PALAZÓN AZORÍ

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years with upper gastrointestinal bleeding defined as hematemesis, melena or coffee\-ground hematemesist. Informed consent provided.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 120
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 120

Exclusion Criteria

  • Allergy, interactions or contraindications to macrolides, previous administration of prokinetic agents in this episode, perforation or previous gastric surgery, history of cardiac arrhytnmias, acute myocardial infarction or cerebrovascular disease in the last 3 weeks, pregnancy or lactation.

Outcomes

Primary Outcomes

Not specified

Similar Trials